Literature DB >> 12790805

Identification of a functional glucocorticoid response element in the promoter of the cyclin-dependent kinase inhibitor p57Kip2.

K Alheim1, J Corness, M K R Samuelsson, L-G Bladh, T Murata, T Nilsson, S Okret.   

Abstract

Glucocorticoids are known regulators of the cell cycle, normally exerting an anti-proliferative effect. We have previously shown that glucocorticoids stimulate expression of p57(Kip2), a member of the Cip/Kip family of cyclin-dependent kinase inhibitors which, in some cell types, may account for the anti-proliferative responses seen after glucocorticoid treatment. The induction of p57(Kip2) involves primary transcriptional effects where no de novo protein synthesis is necessary, suggesting a direct interaction of the glucocorticoid receptor with the p57(Kip2) gene. In this study we have identified a functional glucocorticoid response element (GRE), located 5 kilo bases (kb) upstream of the transcription start site in the human p57(Kip2) promoter. This GRE was functional also when isolated, suggesting a direct transcriptional effect of the glucocorticoid receptor. Furthermore, mutation of this GRE abolished glucocorticoid induction of the reporter gene, whereas mutation of a nearby Sp1 site did not. Using electrophoretic mobility shift assays, we have shown that the -5 kb p57(Kip2) promoter GRE was able to compete with a well-known GRE for glucocorticoid receptor binding. Sequence comparisons with the mouse genome showed that this GRE is highly conserved, further strengthening the biological importance of this site. All these data emphasize the involvement of this GRE in the glucocorticoid-mediated induction of p57(Kip2) expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790805     DOI: 10.1677/jme.0.0300359

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  14 in total

1.  Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity.

Authors:  Y Ma; W D Cress
Journal:  Oncogene       Date:  2006-12-18       Impact factor: 9.867

2.  CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.

Authors:  Yihong Ma; Lu Chen; Gabriela M Wright; Smitha R Pillai; Srikumar P Chellappan; W Douglas Cress
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

3.  A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma.

Authors:  Amitabh Sharma; Jörg Menche; C Chris Huang; Tatiana Ort; Xiaobo Zhou; Maksim Kitsak; Nidhi Sahni; Derek Thibault; Linh Voung; Feng Guo; Susan Dina Ghiassian; Natali Gulbahce; Frédéric Baribaud; Joel Tocker; Radu Dobrin; Elliot Barnathan; Hao Liu; Reynold A Panettieri; Kelan G Tantisira; Weiliang Qiu; Benjamin A Raby; Edwin K Silverman; Marc Vidal; Scott T Weiss; Albert-László Barabási
Journal:  Hum Mol Genet       Date:  2015-01-12       Impact factor: 6.150

4.  Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.

Authors:  Alejandro A Hidalgo; Kristin K Deeb; J Wesley Pike; Candace S Johnson; Donald L Trump
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

5.  E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells.

Authors:  Gerson Rothschild; Xudong Zhao; Antonio Iavarone; Anna Lasorella
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

6.  Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity.

Authors:  Jen-Chywan Wang; Nilesh Shah; Carlos Pantoja; Sebastiaan H Meijsing; Joseph D Ho; Thomas S Scanlan; Keith R Yamamoto
Journal:  Genes Dev       Date:  2006-03-15       Impact factor: 11.361

7.  Identification of glucocorticoid-regulated genes that control cell proliferation during murine respiratory development.

Authors:  Anthony D Bird; Kheng H Tan; P Fredrik Olsson; Malgorzata Zieba; Sharon J Flecknoe; Douglas R Liddicoat; Richard Mollard; Stuart B Hooper; Timothy J Cole
Journal:  J Physiol       Date:  2007-09-27       Impact factor: 5.182

8.  Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer.

Authors:  Stefan Prekovic; Karianne Schuurman; Isabel Mayayo-Peralta; Anna G Manjón; Mark Buijs; Selçuk Yavuz; Max D Wellenstein; Alejandro Barrera; Kim Monkhorst; Anne Huber; Ben Morris; Cor Lieftink; Theofilos Chalkiadakis; Ferhat Alkan; Joana Silva; Balázs Győrffy; Liesbeth Hoekman; Bram van den Broek; Hans Teunissen; Donna O Debets; Tesa Severson; Jos Jonkers; Timothy Reddy; Karin E de Visser; William Faller; Roderick Beijersbergen; Maarten Altelaar; Elzo de Wit; Rene Medema; Wilbert Zwart
Journal:  Nat Commun       Date:  2021-07-16       Impact factor: 14.919

9.  Expression profiling of Dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development.

Authors:  Claudine G James; Veronica Ulici; Jan Tuckermann; T Michael Underhill; Frank Beier
Journal:  BMC Genomics       Date:  2007-07-01       Impact factor: 3.969

10.  Maternal dexamethasone exposure during pregnancy in rats disrupts gonadotropin-releasing hormone neuronal development in the offspring.

Authors:  Wei Ling Lim; Tomoko Soga; Ishwar S Parhar
Journal:  Cell Tissue Res       Date:  2013-12-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.